Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesis
C. K. Kang, B. Choi, S. Kim, S. Park, S. H. Yoon, D. Lee, A. Lee, Y. Ko, E. Chang, J. Jung, P. G. Choe, W. B. Park, E. S. Kim, H. B. Kim, N. J. Kim, , I. Jung
This study identifies clonal hematopoiesis as an independent risk factor for severe COVID-19 in previously healthy patients, revealing distinct immunological and epigenetic signatures.
bioRxiv · Oct 5, 2021 · PreprintImmunology